Science

The current science of scarred-skin recovery

A clinical approach to improving the appearance of scars through measurable outcomes.

Scarblast redefines scar recovery. Developed through advanced scientific research, Scarblast is a breakthrough cosmetic product created to reduce the appearance of skin scarring. Human skin serves as a biological barrier against pathogens and is built through a network of collagen and elastic fibers that provide significant tensile strength while limiting the absorption of external substances, including traditional lotions and creams.

Scarblast is the only topical solution that uses advanced encapsulation and nanotechnology to penetrate the skin barrier and deliver natural active molecules that support mitochondrial biogenesis, a process clinically associated with cellular energy production and skin improvement.

Evaluation Overview

In a controlled study by Continental Clinical Solutions LLC, Scarblast was evaluated and demonstrated significant visible improvement through both objective clinical measurement and real-world participant feedback.

• 26 scar sites evaluated across participants
• Three treatment groups: active, competitor, and placebo
• Diverse demographics, including a range of skin tones and scar types
• No serious adverse events reported

To reduce the bias of subjective claims, the study incorporated device-based measurements. This approach helps verify structural skin improvement through objective metrics rather than visual observation alone.

The Data^†

🞛 94% improvement in scar surface area reduction compared to competitor and placebo, as measured by 3D surface-mapping instruments.

🞛 62.5% of participants achieved meaningful improvement.

🞛 2.78x more effective. Clinical data indicates that Scarblast is nearly three times more likely to deliver meaningful results than standard care. Unlike traditional treatments that show limited improvement until the endpoint, Scarblast accelerated the recovery curve, with significant visible progress observed during the mid-treatment phase.

Why these results are different

By addressing visible redness at its source, this formula targets prolonged vascular activity to achieve 91.8% redness normalization. It also supports tone stability by helping maintain pigment normalization during early recovery, reducing inflammation-driven darkening where standard care often falls short. Finally, it encourages long-term structural smoothing by supporting the skin’s natural remodeling process for measurable, lasting texture improvement.

Consistent performance across skin types

Scar treatments have historically produced inconsistent results across diverse skin tones. This evaluation suggests a meaningful shift. The active treatment delivered uniform, high-performance outcomes across all demographic groups, including melanin-rich darker skin tones, where conventional approaches often underperform. By showing reliable efficacy across skin types, this treatment supports more consistent scar recovery for a broader range of users.

What this means for you

The data suggests that Scarblast supports multiple aspects of visible scar improvement, not just how scars feel, but also how they look over time.

• Smaller size
• Smoother texture
• More even tone
• Reduced visible redness

Each of these outcomes was supported by measurable findings observed during a third-party clinical evaluation.

Explore the product behind the data

Shop ScarBlast
Back to Product

† Based on findings from a controlled clinical evaluation assessing improvements in scar appearance, including texture, pigmentation, redness, and overall visual quality.